Terms: = Colorectal cancer AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990 AND Prognosis
5 results:
1. E-selectin gene S128R polymorphism is associated with poor prognosis in patients with stage II or III colorectal cancer.
Hebbar M; Adenis A; Révillion F; Duhamel A; Romano O; Truant S; Libersa C; Giraud C; Triboulet JP; Pruvot FR; Peyrat JP
Eur J Cancer; 2009 Jul; 45(10):1871-6. PubMed ID: 19361981
[TBL] [Abstract] [Full Text] [Related]
2. Allelic loss of a common microsatellite marker mycl1: a useful prognostic factor of poor outcomes in colorectal cancer.
Kambara T; Sharp GB; Nagasaka T; Takeda M; Sasamoto H; Nakagawa H; Isozaki H; MacPhee DG; Jass JR; Tanaka N; Matsubara N
Clin Cancer Res; 2004 Mar; 10(5):1758-63. PubMed ID: 15014029
[TBL] [Abstract] [Full Text] [Related]
3. [Deletion of YNZ22 and ALU-VPA/mycl1 loci in human colonic adenocarcinoma and postoperative prognosis].
Kashkin KN; Nikolaev AV; Turbin DA; Perevoshchikov AG
Mol Biol (Mosk); 2001; 35(5):798-804. PubMed ID: 11605532
[TBL] [Abstract] [Full Text] [Related]
4. L-myc genotypes in Hong Kong Chinese colorectal carcinoma patients.
Ko JM; Cheung MH; Wong C; Lau K; Tang CM; Kwan MW; Lung ML
Oncol Rep; 1999; 6(2):441-4. PubMed ID: 10023018
[TBL] [Abstract] [Full Text] [Related]
5. Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers.
Young J; Buttenshaw R; Butterworth L; Ward M; Searle J; Leggett B; Chenevix-Trench G
Oncogene; 1994 Apr; 9(4):1053-6. PubMed ID: 7907781
[TBL] [Abstract] [Full Text] [Related]
